Medicine Costs ₹85,000 in the US… Just ₹35 in India..!

A viral video by a woman from United States has sparked debate over global healthcare costs. She revealed that the cancer drug Revlimid, priced at around ₹85,000 in the US, is available in India for as little as ₹35. The stark difference has drawn widespread attention on social media, highlighting disparities in medicine pricing.

In her video, she expressed concern over the expensive healthcare system in the US, stating that patients are burdened with high costs, while India offers affordable treatment options. Netizens reacted strongly, with many suggesting that traveling to India for medicines could be more economical than purchasing them in the US.